Importancia de las inmunizaciones dentro de la estrategia de prevención: El ejemplo de la prevención del cáncer cervicouterino
1. Importancia de las Inmunizaciones dentro de la Estrategia de Prevencion: El Ejemplo de la Prevención del Cáncer Cervicouterino Jon Kim Andrus, M.D. Director Ajunto, OPS Primer Foro-Taller Sobre Vacunacion Academia Nacional de Medicina de Colombia Bogota, Colombia, 29 de Febrero 2012
5. Castellsague X et al. HPV and cervical cancer in the world. Geneva: WHO/ICO Information Center on HPV and Cervical Cancer; 2007 Desafío: la interpretación del PAP
6. Desafío: Bajas tasas de cobertura de tamizaje* *Franco, et al. Vaccine 2008;26S:L88-L95
7. Genotipos VPH en cancer cervical en Latinoamérica Source: Munoz et al,2004 0 20 40 60 80 100 16 55.7% 16+ 18 65.0% 16+18+31+45 16+18+31 72.2% 77.1% 16+18+31+45+33 16+18+31+45+33+35 16+18+31+45+33+35+52 16+18+31+45+33+35+52+58 80.0% 82.7% 85.4% 87.6%
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Notas del editor
77,000 new cases each year 33,000 deaths each year Old paradigm indicated that if the clinical trial data were good, then introducing the vaccine made sense and was justified.
Experiences in countries which have reduced mortality rates, such as Canada, USA, Chile and Costa Rica has shown that cervical cancer can be prevented and controlled through a comprehensive program which includes: Information and Education: to raise awareness of the problem and encourage women to be screened; and Screening and Precancer treatment; and Invasive cancer treatment and palliative care. These components must be linked together and not stand alone services. And in order for the programs to be effective they need to achieve 3 indicators: high screening coverage, follow up and treatment for all women with abnormal screening test results, and high quality screening and treatment. Thus the failure of cervical cancer programs have been related to the inability to achieve these 3 indicators.